ALDOSTERONE SYNTHASE INHIBITORS

The present invention relates to compounds of formula I: (see formula I) and pharmaceutically acceptable salts thereof, wherein Cy, R1 and R2 are as defined herein. The invention also relates to pharmaceutical compositions comprising these compounds, methods of using these compounds in the treatment...

Full description

Saved in:
Bibliographic Details
Main Authors FREDERICK, KOSEA S, CERNY, MATTHEW A, SURPRENANT, SIMON, COGAN, DEREK, MARSHALL, DANIEL RICHARD, YU, MAOLIN, BURKE, JENNIFER, MCKIBBEN, BRYAN P, LORD, JOHN, FADER, LEE, ZHANG, YUNLONG
Format Patent
LanguageEnglish
French
Published 15.11.2022
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention relates to compounds of formula I: (see formula I) and pharmaceutically acceptable salts thereof, wherein Cy, R1 and R2 are as defined herein. The invention also relates to pharmaceutical compositions comprising these compounds, methods of using these compounds in the treatment of a disease or disorder that can be alleviated by inhibition of aldosterone synthase such as diabetic nephropathy, processes for preparing these compounds and intermediates useful in these processes. La présente invention concerne des composés de formule I :et des sels connexes acceptables sur le plan pharmaceutique, Cy, R1 et R2 étant tels que définis dans la présente invention. L'invention concerne également des compositions pharmaceutiques comprenant ces composés, des méthodes d'utilisation des composés dans le traitement d'une maladie ou d'un trouble pouvant être atténué par l'inhibition de la synthase d'aldostérone, comme la néphropathie diabétique, des procédés de préparation des composés et des intermédiaires utiles dans ces procédés.
Bibliography:Application Number: CA20152956118